Results
Gujarat Themis Biosyn Q1 Revenue Up 22% YoY
Gujarat Themis Biosyn reported Q1 FY27 revenue of INR43.8 crores, up 22.1% YoY, with EBITDA margin expanding 867 bps to 47.5%.
Management detailed two major acquisitions: MicroBiopharm Japan for ferme
